Tumor Promoting or Tumor Suppressing of NF-κ B, a Matter of Cell Context Dependency

REFERENCES

• Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986; 46: 705–716
   PubMed Web of Science ®Google Scholar
• Atchison M. L., Perry R. P. The role of the kappa enhancer and its binding factor nf-kappa b in the developmental regulation of kappa gene transcription. Cell 1987; 48: 121–128
   PubMed Web of Science ®Google Scholar
• Sen R., Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein nf-kappa b by a posttranslational mechanism. Cell 1986; 47: 921–928
   PubMed Web of Science ®Google Scholar
• Lin L., Ghosh S. A glycine-rich region in nf-kappab p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol 1996; 16: 2248–2254
   PubMed Web of Science ®Google Scholar
• Lin L., DeMartino G. N., Greene W. C. Cotranslational biogenesis of nf-kappab p50 by the 26s proteasome. Cell 1998; 92: 819–828
   PubMed Web of Science ®Google Scholar
• Chen F., Bhatia D., Chang Q., Castranova V. Finding nemo by k63-linked polyubiquitin chain. Cell Death Differ 2006; 13: 1835–1838
   Google Scholar
• Chen F., Castranova V., Shi X. New insights into the role of nuclear factor-kappab in cell growth regulation. Am J Pathol 2001; 159: 387–397
   PubMed Web of Science ®Google Scholar
• Chen F., Castranova V., Shi X., Demers L. M. New insights into the role of nuclear factor-kappab, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999; 45: 7–17
   PubMed Web of Science ®Google Scholar
• Lin W. W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007; 117: 1175–1183
   PubMed Web of Science ®Google Scholar
• Hussain S. P., Hofseth L. J., Harris C. C. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276–285
   PubMed Web of Science ®Google Scholar
• Chen F., Demers L. M., Vallyathan V., Lu Y., Castranova V., Shi X. Involvement of 5′-flanking kappab-like sites within bcl-x gene in silica-induced bcl-x expression. J Biol Chem 1999; 274: 35591–35595
   PubMed Web of Science ®Google Scholar
• Dixon E. P., Stephenson D. T., Clemens J. A., Little S. P. Bcl-xshort is elevated following severe global ischemia in rat brains. Brain Res 1997; 776: 222–229
   PubMedGoogle Scholar
• Lee H. H., Dadgostar H., Cheng Q., Shu J., Cheng G. Nf-kappab-mediated up-regulation of bcl-x and bfl-1/a1 is required for cd40 survival signaling in b lymphocytes. Proc Natl Acad Sci USA 1999; 96: 9136–9141
   PubMed Web of Science ®Google Scholar
• Houldsworth J., Mathew S., Rao P. H., Dyomina K., Louie D. C., Parsa N., Offit K., Chaganti R. S. Rel proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 1996; 87: 25–29
   PubMed Web of Science ®Google Scholar
• Liptay S., Seriu T., Bartram C. R., Schmid R. M. Germline configuration of nfkb2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (all). Leukemia 1997; 11: 1364–1366
   PubMed Web of Science ®Google Scholar
• Courtois G., Gilmore T. D. Mutations in the nf-kappab signaling pathway: Implications for human disease. Oncogene 2006; 25: 6831–6843
   PubMed Web of Science ®Google Scholar
• Ciana P., Neri A., Cappellini C., Cavallo F., Pomati M., Chang C. C., Maiolo A. T., Lombardi L. Constitutive expression of lymphoma-associated nfkb-2/lyt-10 proteins is tumorigenic in murine fibroblasts. Oncogene 1997; 14: 1805–1810
   PubMed Web of Science ®Google Scholar
• Wood K. M., Roff M., Hay R. T. Defective ikappabalpha in hodgkin cell lines with constitutively active nf-kappab. Oncogene 1998; 16: 2131–2139
   PubMed Web of Science ®Google Scholar
• Brummelkamp T. R., Nijman S. M., Dirac A. M., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating nf-kappab. Nature 2003; 424: 797–801
   PubMed Web of Science ®Google Scholar
• Bignell G. R., Warren W., Seal S., Takahashi M., Rapley E., Barfoot R., Green H., Brown C., Biggs P. J., Lakhani S. R., Jones C., Hansen J., Blair E., Hofmann B., Siebert R., Turner G., Evans D. G., Schrander-Stumpel C., Beemer F. A., van Den Ouweland A., Halley D., Delpech B., Cleveland M. G., Leigh I., Leisti J., Rasmussen S. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000; 25: 160–165
   PubMed Web of Science ®Google Scholar
• Annunziata C. M., Davis R. E., Demchenko Y., Bellamy W., Gabrea A., Zhan F., Lenz G., Hanamura I., Wright G., Xiao W., Dave S., Hurt E. M., Tan B., Zhao H., Stephens O., Santra M., Williams D. R., Dang L., Barlogie B., Shaughnessy J. D., Jr., Kuehl W. M., Staudt L. M. Frequent engagement of the classical and alternative nf-kappab pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007; 12: 115–130
   PubMed Web of Science ®Google Scholar
• Keats J. J., Fonseca R., Chesi M., Schop R., Baker A., Chng W. J., Van Wier S., Tiedemann R., Shi C. X., Sebag M., Braggio E., Henry T., Zhu Y. X., Fogle H., Price-Troska T., Ahmann G., Mancini C., Brents L. A., Kumar S., Greipp P., Dispenzieri A., Bryant B., Mulligan G., Bruhn L., Barrett M., Valdez R., Trent J., Stewart A. K., Carpten J., Bergsagel P. L. Promiscuous mutations activate the noncanonical nf-kappab pathway in multiple myeloma. Cancer Cell 2007; 12: 131–144
   PubMed Web of Science ®Google Scholar
• Woronicz J. D., Gao X., Cao Z., Rothe M., Goeddel D. V. Ikappab kinase-beta: Nf-kappab activation and complex formation with ikappab kinase-alpha and nik. Science 1997; 278: 866–869
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappab in cancer development and progression. Nature 2006; 441: 431–436
   PubMed Web of Science ®Google Scholar
• Chen F. Endogenous inhibitors of nuclear factor-kappab, an opportunity for cancer control. Cancer Res 2004; 64: 8135–8138
   Google Scholar
• Perkins N. D. The rel/nf-kappa b family: Friend and foe. Trends Biochem Sci 2000; 25: 434–440
   PubMed Web of Science ®Google Scholar
• Baldwin A. S. Control of oncogenesis and cancer therapy resistance by the transcription factor nf-kappab. J Clin Invest 2001; 107: 241–246
   PubMed Web of Science ®Google Scholar
• Gilmore T. D. Multiple myeloma: Lusting for nf-kappab. Cancer Cell 2007; 12: 95–97
   PubMed Web of Science ®Google Scholar
• Chen F., Castranova V. Nuclear factor-kappab, an unappreciated tumor suppressor. Cancer Res 2007; 67: 11093–11098
   PubMed Web of Science ®Google Scholar
• Perkins N. D. Nf-kappab: Tumor promoter or suppressor?. Trends Cell Biol 2004; 14: 64–69
   PubMed Web of Science ®Google Scholar
• Kasibhatla S., Brunner T., Genestier L., Echeverri F., Mahboubi A., Green D. R. DNA damaging agents induce expression of fas ligand and subsequent apoptosis in t lymphocytes via the activation of nf-kappa b and ap-1. Mol Cell 1998; 1: 543–551
   PubMed Web of Science ®Google Scholar
• Hettmann T., DiDonato J., Karin M., Leiden J. M. An essential role for nuclear factor kappab in promoting double positive thymocyte apoptosis. J Exp Med 1999; 189: 145–158
   PubMed Web of Science ®Google Scholar
• Bash J., Zong W. X., Gelinas C. C-rel arrests the proliferation of hela cells and affects critical regulators of the g1/s-phase transition. Mol Cell Biol 1997; 17: 6526–6536
   PubMed Web of Science ®Google Scholar
• Seitz C. S., Lin Q., Deng H., Khavari P. A. Alterations in nf-kappab function in transgenic epithelial tissue demonstrate a growth inhibitory role for nf-kappab. Proc Natl Acad Sci U S A 1998; 95: 2307–2312
   PubMed Web of Science ®Google Scholar
• Liu B., Park E., Zhu F., Bustos T., Liu J., Shen J., Fischer S. M., Hu Y. A critical role for i kappab kinase alpha in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci USA 2006; 103: 17202–17207
   Google Scholar
• Maeda S., Kamata H., Luo J. L., Leffert H., Karin M. Ikkbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005; 121: 977–990
   PubMed Web of Science ®Google Scholar
• Luedde T., Beraza N., Kotsikoris V., van Loo G., Nenci A., De Vos R., Roskams T., Trautwein C., Pasparakis M. Deletion of nemo/ikkgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007; 11: 119–132
   PubMed Web of Science ®Google Scholar
• Zhang Y., Chen F. Reactive oxygen species (ros), troublemakers between nuclear factor-kappab (nf-kappab) and c-jun nh(2)-terminal kinase (jnk). Cancer Res 2004; 64: 1902–1905
   PubMed Web of Science ®Google Scholar
• Chen F., Lu Y., Zhang Z., Vallyathan V., Ding M., Castranova V., Shi X. Opposite effect of nf-kappa b and c-jun n-terminal kinase on p53-independent gadd45 induction by arsenite. J Biol Chem 2001; 276: 11414–11419
   PubMed Web of Science ®Google Scholar
• De Smaele E., Zazzeroni F., Papa S., Nguyen D. U., Jin R., Jones J., Cong R., Franzoso G. Induction of gadd45beta by nf-kappab downregulates pro-apoptotic jnk signalling. Nature 2001; 414: 308–313
   PubMed Web of Science ®Google Scholar
• Tang G., Minemoto Y., Dibling B., Purcell N. H., Li Z., Karin M., Lin A. Inhibition of jnk activation through nf-kappab target genes. Nature 2001; 414: 313–317
   PubMed Web of Science ®Google Scholar
• Heasley L. E., Han S. Y. Jnk regulation of oncogenesis. Mol Cells 2006; 21: 167–173
   PubMed Web of Science ®Google Scholar
• Chen N., Nomura M., She Q. B., Ma W. Y., Bode A. M., Wang L., Flavell R. A., Dong Z. Suppression of skin tumorigenesis in c-jun nh(2)-terminal kinase-2-deficient mice. Cancer Res 2001; 61: 3908–3912
   PubMed Web of Science ®Google Scholar
• Bost F., McKay R., Bost M., Potapova O., Dean N. M., Mercola D. The jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human a549 lung carcinoma cells. Mol Cell Biol 1999; 19: 1938–1949
   PubMed Web of Science ®Google Scholar
• Schreck R., Albermann K., Baeuerle P. A. Nuclear factor kappa b: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 1992; 17: 221–237
   PubMed Web of Science ®Google Scholar
• Das K. C., Lewis-Molock Y., White C. W. Activation of nf-kappa b and elevation of mnsod gene expression by thiol reducing agents in lung adenocarcinoma (a549) cells. Am J Physiol 1995; 269: L588–602
   PubMedGoogle Scholar
• Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., Kojima Y., Piao J. H., Yagita H., Okumura K., Doi T., Nakano H. Nf-kappab inhibits tnf-induced accumulation of ros that mediate prolonged mapk activation and necrotic cell death. EMBO J 2003; 22: 3898–3909
   PubMed Web of Science ®Google Scholar
• Chen F., Castranova V., Li Z., Karin M., Shi X. Inhibitor of nuclear factor kappab kinase deficiency enhances oxidative stress and prolongs c-jun nh2-terminal kinase activation induced by arsenic. Cancer Res 2003; 63: 7689–7693
   PubMedGoogle Scholar
• Guengerich F. P. Common and uncommon cytochrome p450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 2001; 14: 611–650
   PubMed Web of Science ®Google Scholar
• Peng Z., Peng L., Fan Y., Zandi E., Shertzer H. G., Xia Y. A critical role for ikappab kinase beta in metallothionein-1 expression and protection against arsenic toxicity. J Biol Chem 2007; 282: 21487–21496
   Google Scholar
• Slack J. M. Conrad Hal Waddington: The last renaissance biologist?. Nat Rev Genet 2002; 3: 889–895
   PubMed Web of Science ®Google Scholar
• Waddington C. H. Intruduction to Modern Genetics. George Allen & Unwin, London 1939
   Google Scholar
• Holliday R. Epigenetics: A historical overview. Epigenetics 2006; 1: 76–80
   PubMed Web of Science ®Google Scholar
• Whetstine J. R., Nottke A., Lan F., Huarte M., Smolikov S., Chen Z., Spooner E., Li E., Zhang G., Colaiacovo M., Shi Y. Reversal of histone lysine trimethylation by the jmjd2 family of histone demethylases. Cell 2006; 125: 467–481
   PubMed Web of Science ®Google Scholar
• Bannister A. J., Kouzarides T. Reversing histone methylation. Nature 2005; 436: 1103–1106
   PubMed Web of Science ®Google Scholar
• Shi Y., Lan F., Matson C., Mulligan P., Whetstine J. R., Cole P. A., Casero R. A., Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog lsd1. Cell 2004; 119: 941–953
   PubMed Web of Science ®Google Scholar
• Cloos P. A., Christensen J., Agger K., Maiolica A., Rappsilber J., Antal T., Hansen K. H., Helin K. The putative oncogene gasc1 demethylates tri- and dimethylated lysine 9 on histone h3. Nature 2006; 442: 307–311
   PubMed Web of Science ®Google Scholar
• Fodor B. D., Kubicek S., Yonezawa M., O'Sullivan R. J., Sengupta R., Perez-Burgos L., Opravil S., Mechtler K., Schotta G., Jenuwein T. Jmjd2b antagonizes h3k9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 2006; 20: 1557–1562
   PubMed Web of Science ®Google Scholar
• Tsukada Y., Fang J., Erdjument-Bromage H., Warren M. E., Borchers C. H., Tempst P., Zhang Y. Histone demethylation by a family of jmjc domain-containing proteins. Nature 2006; 439: 811–816
   PubMed Web of Science ®Google Scholar
• Yamane K., Toumazou C., Tsukada Y., Erdjument-Bromage H., Tempst P., Wong J., Zhang Y. Jhdm2a, a jmjc-containing h3k9 demethylase, facilitates transcription activation by androgen receptor. Cell 2006; 125: 483–495
   PubMed Web of Science ®Google Scholar
• Huyen Y., Zgheib O., Ditullio R. A., Jr., Gorgoulis V. G., Zacharatos P., Petty T. J., Sheston E. A., Mellert H. S., Stavridi E. S., Halazonetis T. D. Methylated lysine 79 of histone h3 targets 53bp1 to DNA double-strand breaks. Nature 2004; 432: 406–411
   PubMed Web of Science ®Google Scholar
• De Santa F., Totaro M. G., Prosperini E., Notarbartolo S., Testa G., Natoli G. The histone h3 lysine-27 demethylase jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130: 1083–1094
   PubMed Web of Science ®Google Scholar
• Chen F., Lu Y., Castranova V., Li Z., Karin M. Loss of ikkbeta promotes migration and proliferation of mouse embryo fibroblast cells. J Biol Chem 2006; 281: 37142–37149
   PubMedGoogle Scholar
• Irelan J. T., Murphy T. J., DeJesus P. D., Teo H., Xu D., Gomez-Ferreria M. A., Zhou Y., Miraglia L. J., Rines D. R., Verma I. M., Sharp D. J., Tergaonkar V., Chanda S. K. A role for ikappab kinase 2 in bipolar spindle assembly. Proc Natl Acad Sci U S A 2007; 104: 16940–16945
   PubMed Web of Science ®Google Scholar
• Prajapati S., Tu Z., Yamamoto Y., Gaynor R. B. Ikkalpha regulates the mitotic phase of the cell cycle by modulating aurora a phosphorylation. Cell Cycle 2006; 5: 2371–2380
   PubMed Web of Science ®Google Scholar
• Ihrie R. A., Marques M. R., Nguyen B. T., Horner J. S., Papazoglu C., Bronson R. T., Mills A. A., Attardi L. D. Perp is a p63-regulated gene essential for epithelial integrity. Cell 2005; 120: 843–856
   PubMed Web of Science ®Google Scholar
• Gilmore T. D., Herscovitch M. Inhibitors of nf-kappab signaling: 785 and counting. Oncogene 2006; 25: 6887–6899
   PubMed Web of Science ®Google Scholar